180 related articles for article (PubMed ID: 34943979)
1. A Promising Combination: PACAP and PARP Inhibitor Have Therapeutic Potential in Models of Diabetic and Hypertensive Retinopathies.
Pöstyéni E; Szabadfi K; Sétáló G; Gabriel R
Cells; 2021 Dec; 10(12):. PubMed ID: 34943979
[TBL] [Abstract][Full Text] [Related]
2. PACAP promotes neuron survival in early experimental diabetic retinopathy.
Szabadfi K; Szabo A; Kiss P; Reglodi D; Setalo G; Kovacs K; Tamas A; Toth G; Gabriel R
Neurochem Int; 2014 Jan; 64():84-91. PubMed ID: 24262293
[TBL] [Abstract][Full Text] [Related]
3. Pituitary Adenylate Cyclase Activating Polypeptide, A Potential Therapeutic Agent for Diabetic Retinopathy in Rats: Focus on the Vertical Information Processing Pathway.
Szabadfi K; Reglodi D; Szabo A; Szalontai B; Valasek A; Setalo G; Kiss P; Tamas A; Wilhelm M; Gabriel R
Neurotox Res; 2016 Apr; 29(3):432-46. PubMed ID: 26739825
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of the neuropeptide PACAP in diabetic retinopathy.
Szabadfi K; Atlasz T; Kiss P; Reglodi D; Szabo A; Kovacs K; Szalontai B; Setalo G; Banki E; Csanaky K; Tamas A; Gabriel R
Cell Tissue Res; 2012 Apr; 348(1):37-46. PubMed ID: 22350850
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of PACAP-38 on retinal pigmented epithelium in an in vitro and in vivo model of diabetic retinopathy through EGFR-dependent mechanism.
Maugeri G; D'Amico AG; Bucolo C; D'Agata V
Peptides; 2019 Sep; 119():170108. PubMed ID: 31247223
[TBL] [Abstract][Full Text] [Related]
6. PACAP Modulates Expression of Hypoxia-Inducible Factors in Streptozotocin-Induced Diabetic Rat Retina.
D'Amico AG; Maugeri G; Reitano R; Bucolo C; Saccone S; Drago F; D'Agata V
J Mol Neurosci; 2015 Dec; 57(4):501-9. PubMed ID: 26202258
[TBL] [Abstract][Full Text] [Related]
7. Effect of the regimen of Gaoshan Hongjingtian on the mechanism of poly (ADP-ribose) polymerase regulation of nuclear factor kappa B in the experimental diabetic retinopathy.
Zhao HS; Shi XY; Wei WB; Wang NL
Chin Med J (Engl); 2013; 126(9):1693-9. PubMed ID: 23652053
[TBL] [Abstract][Full Text] [Related]
8. Involvement of brain-derived neurotrophic factor in early retinal neuropathy of streptozotocin-induced diabetes in rats: therapeutic potential of brain-derived neurotrophic factor for dopaminergic amacrine cells.
Seki M; Tanaka T; Nawa H; Usui T; Fukuchi T; Ikeda K; Abe H; Takei N
Diabetes; 2004 Sep; 53(9):2412-9. PubMed ID: 15331553
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors Reduce Reactive Gliosis and Improve Angiostatin Levels in Retina of Diabetic Rats.
Guzyk MM; Tykhomyrov AA; Nedzvetsky VS; Prischepa IV; Grinenko TV; Yanitska LV; Kuchmerovska TM
Neurochem Res; 2016 Oct; 41(10):2526-2537. PubMed ID: 27255598
[TBL] [Abstract][Full Text] [Related]
10. Exogenous SOD mimetic tempol ameliorates the early retinal changes reestablishing the redox status in diabetic hypertensive rats.
Rosales MA; Silva KC; Lopes de Faria JB; Lopes de Faria JM
Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4327-36. PubMed ID: 20335612
[TBL] [Abstract][Full Text] [Related]
11. PACAP-mediated neuroprotection of neurochemically identified cell types in MSG-induced retinal degeneration.
Atlasz T; Szabadfi K; Kiss P; Babai N; Koszegi Z; Tamas A; Reglodi D; Gabriel R
J Mol Neurosci; 2008 Nov; 36(1-3):97-104. PubMed ID: 18418735
[TBL] [Abstract][Full Text] [Related]
12. Loss of cholinergic and dopaminergic amacrine cells in streptozotocin-diabetic rat and Ins2Akita-diabetic mouse retinas.
Gastinger MJ; Singh RS; Barber AJ
Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3143-50. PubMed ID: 16799061
[TBL] [Abstract][Full Text] [Related]
13. Early changes in pituitary adenylate cyclase-activating peptide, vasoactive intestinal peptide and related receptors expression in retina of streptozotocin-induced diabetic rats.
Giunta S; Castorina A; Bucolo C; Magro G; Drago F; D'Agata V
Peptides; 2012 Sep; 37(1):32-9. PubMed ID: 22721946
[TBL] [Abstract][Full Text] [Related]
14. Accelerated retinal aging in PACAP knock-out mice.
Kovács-Valasek A; Szabadfi K; Dénes V; Szalontai B; Tamás A; Kiss P; Szabó A; Setalo G; Reglődi D; Gábriel R
Neuroscience; 2017 Apr; 348():1-10. PubMed ID: 28215987
[TBL] [Abstract][Full Text] [Related]
15. Poly(ADP-ribose)polymerase inhibition counteracts cataract formation and early retinal changes in streptozotocin-diabetic rats.
Drel VR; Xu W; Zhang J; Kador PF; Ali TK; Shin J; Julius U; Slusher B; El-Remessy AB; Obrosova IG
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1778-90. PubMed ID: 19098320
[TBL] [Abstract][Full Text] [Related]
16. Effect of PACAP treatment on kidney morphology and cytokine expression in rat diabetic nephropathy.
Banki E; Degrell P; Kiss P; Kovacs K; Kemeny A; Csanaky K; Duh A; Nagy D; Toth G; Tamas A; Reglodi D
Peptides; 2013 Apr; 42():125-30. PubMed ID: 23416022
[TBL] [Abstract][Full Text] [Related]
17. Up-regulated expression of neuronal nitric oxide synthase in experimental diabetic retina.
Park JW; Park SJ; Park SH; Kim KY; Chung JW; Chun MH; Oh SJ
Neurobiol Dis; 2006 Jan; 21(1):43-9. PubMed ID: 16023354
[TBL] [Abstract][Full Text] [Related]
18. Shifting of parvalbumin expression in the rat retina in experimentally induced diabetes.
Park HS; Park SJ; Park SH; Chun MH; Oh SJ
Acta Neuropathol; 2008 Feb; 115(2):241-8. PubMed ID: 17989985
[TBL] [Abstract][Full Text] [Related]
19. Retinoprotective effect of agmatine in streptozotocin-induced diabetic rat model: avenues for vascular and neuronal protection : Agmatine in diabetic retinopathy.
Abo El Gheit RE; Soliman NA; Badawi GA; Madi NM; El-Saka MH; Badr SM; Emam MN
J Physiol Biochem; 2021 May; 77(2):305-320. PubMed ID: 33635523
[TBL] [Abstract][Full Text] [Related]
20. Novel features of neurodegeneration in the inner retina of early diabetic rats.
Énzsöly A; Szabó A; Szabó K; Szél Á; Németh J; Lukáts Á
Histol Histopathol; 2015 Aug; 30(8):971-85. PubMed ID: 25760641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
